Literature DB >> 1679907

Virulence determinants of Escherichia coli O6 extraintestinal isolates analysed by Southern hybridizations and DNA long range mapping techniques.

G Blum1, M Ott, A Cross, J Hacker.   

Abstract

A total of 16 Escherichia coli O6 strains isolated from cases of extraintestinal infections were analysed for the genetic presence and phenotypic expression of fimbrial adhesins (P, S/FIC, type 1), aerobactin and hemolysin. In addition restriction fragment length polymorphisms (RFLPs) of Xbal-cleaved genomic DNA of seven selected strains, separated by orthogonal field alternation gel electrophoresis (OFAGE) were determined and virulence-associated DNA probes were used for Southern hybridization studies of the Xbal-cleaved genomic DNAs. The virulence characteristics and hybridization patterns obtained differed between the various isolates. In three isolates hemolysin genes and P fimbrial determinants were located on the same Xbal fragments. Furthermore, multiple copies of FIC determinants (foc) could be detected in two strains. Our data show that the new technique of pulse field electrophoresis together with Southern hybridization represents a powerful tool for the genetic analysis of pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679907     DOI: 10.1016/0882-4010(91)90073-j

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536.

Authors:  U Dobrindt; G Blum-Oehler; T Hartsch; G Gottschalk; E Z Ron; R Fünfstück; J Hacker
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Oral administration of a certain strain of live Escherichia coli for intestinal disorders? Artificial contamination and manipulation of the digestive tract--our poor GIT!

Authors: 
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

3.  Transcriptional analysis and regulation of the sfa determinant coding for S fimbriae of pathogenic Escherichia coli strains.

Authors:  J Morschhäuser; B E Uhlin; J Hacker
Journal:  Mol Gen Genet       Date:  1993-04

4.  Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.

Authors:  J R Johnson; T T O'Bryan; M Kuskowski; J N Maslow
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Clonal differentiation of uropathogenic Escherichia coli isolates of serotype O6:K5 by fimbrial antigen typing and DNA long-range mapping techniques.

Authors:  G Zingler; G Blum; U Falkenhagen; I Orskov; F Orskov; J Hacker; M Ott
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

6.  Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18:K1 meningitis isolate.

Authors:  J Hacker; H Kestler; H Hoschützky; K Jann; F Lottspeich; T K Korhonen
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Structure and copy number analyses of pap-, sfa-, and afa-related gene clusters in F165-positive bovine and porcine Escherichia coli isolates.

Authors:  S N Maiti; J Harel; J M Fairbrother
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Properties of Escherichia coli strains of serotype O6.

Authors:  G Blum; R Marre; J Hacker
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

9.  Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.

Authors:  M Ngeleka; J Harel; M Jacques; J M Fairbrother
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Distribution, expression, and long-range mapping of legiolysin gene (lly)-specific DNA sequences in legionellae.

Authors:  L Bender; M Ott; A Debes; U Rdest; J Heesemann; J Hacker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.